Opinion: STAT+: Why Silicon Valley should demand clinical trials for its medical AI
For AI tools making high-stakes clinical decisions, well-designed, prospective RCTs must be the gold standard.
Previous Post
Brain Fog Nation – The Attention That Left Us
Next Post
Public Health Is Not the Hudson River – The Health Care Blog
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago